| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 2 465-472, Copyright © 1996 by American Association of Immunologists
ARTICLES |
TF Gajewski
Ludwig Institute for Cancer Research, Brussels Branch, Catholic University of Louvain, Belgium.
We recently have developed a method to generate primary P815-specific CTL in vitro from normal syngeneic splenocytes by employing transfection of B7-1 combined with exogenous IL-12 and IL-6. Surprisingly, when the homologous costimulator molecule B7-2 was substituted for B7-1 in this system, no specific CTL activity was obtained. Similarly, B7-1- but not B7-2-transfected P815 cells generated alloantigen-specific CTL activity from C57BL/6, accessory cell- and CD4(+)-depleted splenocytes, and costimulated proliferation of CD8+ lymphocytes in the presence of low doses of anti-CD3 mAb. In all systems, combined expression of both B7-1 and B7-2 costimulated as effectively as B7-1 alone, arguing against delivery of a dominant negative signal by B7-2. Proliferation of allogeneic, CD4(+)-depleted splenocytes in response to P815 cells, which relies on costimulation by normal accessory cells, was inhibited by anti-B7-1 but not anti-B7-2 mAbs. Finally, indirect evidence suggested a higher avidity of B7-1+ cells than B7-2+ cells for CTLA4. Thus, at least in the context of primary stimulation by irradiated P815 transfectants, B7-1 appears to be superior to B7-2 at costimulation of CD8+ T lymphocytes.
This article has been cited by other articles:
|
|
 |
|
  S. Pejawar-Gaddy and M. A. Alexander-Miller Ligation of CD80 Is Critical for High-Level CD25 Expression on CD8+ T Lymphocytes J. Immunol., October 1, 2006; 177(7): 4495 - 4502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Brown, C. Blank, J. Kline, A. K. Kacha, and T. F. Gajewski Homeostatic Proliferation as an Isolated Variable Reverses CD8+ T Cell Anergy and Promotes Tumor Rejection J. Immunol., October 1, 2006; 177(7): 4521 - 4529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schneider, E. Valk, S. da Rocha Dias, B. Wei, and C. E. Rudd CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function PNAS, September 6, 2005; 102(36): 12861 - 12866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Pejawar, G. D. Parks, and M. A. Alexander-Miller Abortive versus Productive Viral Infection of Dendritic Cells with a Paramyxovirus Results in Differential Upregulation of Select Costimulatory Molecules J. Virol., June 15, 2005; 79(12): 7544 - 7557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Blank, I. Brown, A. K. Kacha, M. A. Markiewicz, and T. F. Gajewski ICAM-1 Contributes to but Is Not Essential for Tumor Antigen Cross-Priming and CD8+ T Cell-Mediated Tumor Rejection In Vivo J. Immunol., March 15, 2005; 174(6): 3416 - 3420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blank, I. Brown, A. C. Peterson, M. Spiotto, Y. Iwai, T. Honjo, and T. F. Gajewski PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells Cancer Res., February 1, 2004; 64(3): 1140 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Blank, I. Brown, R. Marks, H. Nishimura, T. Honjo, and T. F. Gajewski Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells J. Immunol., November 1, 2003; 171(9): 4574 - 4581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Agadjanyan, M. A. Chattergoon, M. J. Holterman, B. Monzavi-Karbassi, J. J. Kim, T. Dentchev, D. Wilson, V. Ayyavoo, L. J. Montaner, T. Kieber-Emmons, et al. Costimulatory Molecule Immune Enhancement in a Plasmid Vaccine Model Is Regulated in Part Through the Ig Constant-Like Domain of CD80/86 J. Immunol., October 15, 2003; 171(8): 4311 - 4319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. M. Haeryfar, M. M. Al-alwan, J. S. Mader, G. Rowden, K. A. West, and D. W. Hoskin Thy-1 Signaling in the Context of Costimulation Provided by Dendritic Cells Provides Signal 1 for T Cell Proliferation and Cytotoxic Effector Molecule Expression, but Fails to Trigger Delivery of the Lethal Hit J. Immunol., July 1, 2003; 171(1): 69 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Hwang, W. B. Sweatt, I. E. Brown, C. Blank, T. F. Gajewski, J. A. Bluestone, and M.-L. Alegre Cutting Edge: Targeted Ligation of CTLA-4 In Vivo by Membrane-Bound Anti-CTLA-4 Antibody Prevents Rejection of Allogeneic Cells J. Immunol., July 15, 2002; 169(2): 633 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. LaBelle, C. A. Hanke, B. R. Blazar, and R. L. Truitt Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia Blood, March 15, 2002; 99(6): 2146 - 2153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Mittrucker, M. Kursar, A. Kohler, R. Hurwitz, and S. H. E. Kaufmann Role of CD28 for the Generation and Expansion of Antigen-Specific CD8+ T Lymphocytes During Infection with Listeria monocytogenes J. Immunol., November 15, 2001; 167(10): 5620 - 5627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Staats, C. P. Bradney, W. M. Gwinn, S. S. Jackson, G. D. Sempowski, H.-X. Liao, N. L. Letvin, and B. F. Haynes Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization J. Immunol., November 1, 2001; 167(9): 5386 - 5394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Donepudi, P. Raychaudhuri, J. A. Bluestone, and M. B. Mokyr Mechanism of Melphalan-Induced B7-1 Gene Expression in P815 Tumor Cells J. Immunol., June 1, 2001; 166(11): 6491 - 6499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Notter, T. Willinger, U. Erben, and E. Thiel Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells Blood, May 15, 2001; 97(10): 3138 - 3145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chan, D. J. Lee, A. Schubert, C. M. Tang, B. Crain, S. P. Schoenberger, and M. Corr The Roles of MHC Class II, CD40, and B7 Costimulation in CTL Induction by Plasmid DNA J. Immunol., March 1, 2001; 166(5): 3061 - 3066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Santra, D. H. Barouch, S. S. Jackson, M. J. Kuroda, J. E. Schmitz, M. A. Lifton, A. H. Sharpe, and N. L. Letvin Functional Equivalency of B7-1 and B7-2 for Costimulating Plasmid DNA Vaccine-Elicited CTL Responses J. Immunol., December 15, 2000; 165(12): 6791 - 6795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. McAdam, B. E. Gewurz, E. A. Farkash, and A. H. Sharpe Either B7 Costimulation or IL-2 Can Elicit Generation of Primary Alloreactive CTL J. Immunol., September 15, 2000; 165(6): 3088 - 3093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Sojka, M. Donepudi, J. A. Bluestone, and M. B. Mokyr Melphalan and Other Anticancer Modalities Up-Regulate B7-1 Gene Expression in Tumor Cells J. Immunol., June 15, 2000; 164(12): 6230 - 6236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mozdzanowska, K. Maiese, and W. Gerhard Th Cell-Deficient Mice Control Influenza Virus Infection More Effectively Than Th- and B Cell-Deficient Mice: Evidence for a Th-Independent Contribution by B Cells to Virus Clearance J. Immunol., March 1, 2000; 164(5): 2635 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wang, R. Maile, R. Greenwood, E. J. Collins, and J. A. Frelinger Naive CD8+ T Cells Do Not Require Costimulation for Proliferation and Differentiation into Cytotoxic Effector Cells J. Immunol., February 1, 2000; 164(3): 1216 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Martin-Fontecha, M. Moro, M. C. Crosti, F. Veglia, G. Casorati, and P. Dellabona Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity J. Immunol., January 15, 2000; 164(2): 698 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. McAdam, E. A. Farkash, B. E. Gewurz, and A. H. Sharpe B7 Costimulation Is Critical for Antibody Class Switching and CD8+ Cytotoxic T-Lymphocyte Generation in the Host Response to Vesicular Stomatitis Virus J. Virol., January 1, 2000; 74(1): 203 - 208. [Abstract] [Full Text]
|
|
|
|
|
|
M. Moro, A. M. Gasparri, S. Pagano, M. Bellone, P. Tornaghi, F. Veglia, A. Corti, G. Casorati, and P. Dellabona Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules Cancer Res., June 1, 1999; 59(11): 2650 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Martin, J. G. Frelinger, and J. P.-Y. Ting Combination Gene Therapy with CD86 and the MHC Class II Transactivator in the Control of Lung Tumor Growth J. Immunol., June 1, 1999; 162(11): 6663 - 6670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-a. Guinn, M. A. DeBenedette, T. H. Watts, and N. L. Berinstein 4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine J. Immunol., April 15, 1999; 162(8): 5003 - 5010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stremmel, E.A. Greenfield, E. Howard, G.J. Freeman, and V.K. Kuchroo B7-2 Expressed on EL4 Lymphoma Suppresses Antitumor Immunity by an Interleukin 4-dependent Mechanism J. Exp. Med., March 15, 1999; 189(6): 919 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Agadjanyan, J. J. Kim, N. Trivedi, D. M. Wilson, B. Monzavi-Karbassi, L. D. Morrison, L. K. Nottingham, T. Dentchev, A. Tsai, K. Dang, et al. CD86 (B7-2) Can Function to Drive MHC-Restricted Antigen-Specific CTL Responses In Vivo J. Immunol., March 15, 1999; 162(6): 3417 - 3427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Maxwell, J. D. Campbell, C. H. Kim, and A. T. Vella CD40 Activation Boosts T Cell Immunity In Vivo by Enhancing T Cell Clonal Expansion and Delaying Peripheral T Cell Deletion J. Immunol., February 15, 1999; 162(4): 2024 - 2034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Slavik, J. E. Hutchcroft, and B. E. Bierer CD80 and CD86 Are Not Equivalent in Their Ability to Induce the Tyrosine Phosphorylation of CD28 J. Biol. Chem., January 29, 1999; 274(5): 3116 - 3124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. La Motte, A. H. Sharpe, J. A. Bluestone, and M. B. Mokyr Importance of B7-1-Expressing Host Antigen-Presenting Cells for the Eradication of B7-2 Transfected P815 Tumor Cells J. Immunol., December 15, 1998; 161(12): 6552 - 6558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Fields, R. J. Finch, G. S. Gray, R. Zollner, J. L. Thomas, K. Sturmhoefel, K. Lee, S. Wolf, T. F. Gajewski, and F. W. Fitch B7.1 Is a Quantitatively Stronger Costimulus Than B7.2 in the Activation of Naive CD8+ TCR-Transgenic T Cells J. Immunol., November 15, 1998; 161(10): 5268 - 5275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Sigal, H. Reiser, and K. L. Rock The Role of B7-1 and B7-2 Costimulation for the Generation of CTL Responses In Vivo J. Immunol., September 15, 1998; 161(6): 2740 - 2745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hermann, M. Rubio, T. Nakajima, G. Delespesse, and M. Sarfati IFN-{alpha} Priming of Human Monocytes Differentially Regulates Gram-Positive and Gram-Negative Bacteria-Induced IL-10 Release and Selectively Enhances IL-12p70, CD80, and MHC Class I Expression J. Immunol., August 15, 1998; 161(4): 2011 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Challita-Eid, M. L. Penichet, S.-U. Shin, T. Poles, N. Mosammaparast, K. Mahmood, D. J. Slamon, S. L. Morrison, and J. D. Rosenblatt A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate Via the T Cell Costimulatory Pathway J. Immunol., April 1, 1998; 160(7): 3419 - 3426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Horspool, P. J. Perrin, J. B. Woodcock, J. H. Cox, C. L. King, C. H. June, D. M. Harlan, D. C. St. Louis, and K. P. Lee Nucleic Acid Vaccine-Induced Immune Responses Require CD28 Costimulation and Are Regulated by CTLA4 J. Immunol., March 15, 1998; 160(6): 2706 - 2714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kozono, R. Abe, H. Kozono, R. G. Kelly, T. Azuma, and V. M. Holers Cross-Linking CD21/CD35 or CD19 Increases Both B7-1 and B7-2 Expression on Murine Splenic B Cells J. Immunol., February 15, 1998; 160(4): 1565 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Dunussi-Joannopoulos, G. Dranoff, H. J. Weinstein, J. L.M. Ferrara, B. E. Bierer, and J. M. Croop Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines Blood, January 1, 1998; 91(1): 222 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Putzer, M. Hitt, W. J. Muller, P. Emtage, J. Gauldie, and F. L. Graham Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression PNAS, September 30, 1997; 94(20): 10889 - 10894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bounou, N. Dumais, and M. J. Tremblay Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-kappa B- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription J. Biol. Chem., February 23, 2001; 276(9): 6359 - 6369. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
